Three-dimensional fibroblast cultures stimulate improved ventricular performance in chronically ischemic canine hearts

Tissue Engineering - Part A

Volumn 17, Issue 17-18, 2011, Pages 2177-2186

  Kellar, Robert S ^a,b   Williams, Stuart K ^c   Naughton, Gail K ^a   Figliozzi, Gianine M ^a   Siani Rose, Michael ^a  

^a Theregen Inc   (United States)

^b Development Engineering Sciences   (United States)

^c Cardiovascular Innovation Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; FIBROBLASTS; SCAFFOLDS; THREE DIMENSIONAL;

AFTER-TREATMENT; BIOLOGICAL EFFECTS; CARDIAC OUTPUT; DATA SUPPORT; DOSING LEVEL; END-SYSTOLIC VOLUMES; HUMAN DERMAL FIBROBLASTS; LEFT VENTRICULAR; LEFT VENTRICULAR EJECTION FRACTION; MYOCARDIAL ISCHEMIA; THREE-DIMENSIONAL FIBROBLAST CULTURES; TIME POINTS; VENTRICULAR WALL MOTION; WALL MOTION; WALL THICKENING;

ANIMALS;

AMEROIDEA; ANIMALIA;

ANIMAL; ARTICLE; CELL CULTURE; DOG; ECHOCARDIOGRAPHY; FIBROBLAST; HEART MUSCLE ISCHEMIA; HEART VENTRICLE; HUMAN; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

ANIMALS; CELLS, CULTURED; DOGS; ECHOCARDIOGRAPHY; FIBROBLASTS; HEART VENTRICLES; HUMANS; MICE; MICE, SCID; MYOCARDIAL ISCHEMIA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80053149603     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0680     Document Type: Article

References (26)

1. Lee, S.U., Wykrzykowska, J.J., and Laham, R.J. Angiogenesis: bench to Bedside, HaveWe Learned Anything? Toxicol Pathol 34, 3, 2006.
2. Beijk, M.A., Koch, K.T., Tijssen, J.G., Henriques, J.P., Baan, J., Vis, M.M., Meesterman, M.G., Piek, J.J., and de Winter, R.J. A retrospective analysis of consecutive patients undergoing nonurgent percutaneous coronary intervention comparing bare metal stents with drug-eluting stents using the National Institute for Clinical Excellence criteria. Coron Artery Dis 22, 32, 2011.
3. Kim, H.T., Nam, C.W., Hur, S.H., Kim, K.B., Lee, S.H., Hong, G.R., Park, J.S., Kim, Y.J., Kim, U., Yang, T.H., Kim, D.I., and Kim, D.S. Two-year clinical outcomes after large coronary stent (4.0mm) placement: comparison of baremetal stent versus drug-eluting stent. Clin Cardiol 33, 620, 2010.
4. Greenwald, S.E., and Berry, C.L. Improving vascular grafts: the importance of mechanical and haemodynamic properties. J Pathol 190, 292, 2000.
5. Boodhwani, M., Sodha, N.R., Laham, R.J., and Sellke, F.W. The future of therapeutic myocardial angiogenesis. Shock 26, 332, 2006.
6. Williams, B., Menon, M., Satran, D., Hayward, D., Hodges, J.S., Burke, M.N., Johnson, R.K., Poulose, A.K., Traverse, J.H., and Henry, T.D. Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality. Catheter Cardiovasc Interv 75, 886, 2010.
7. Symes, J.F., Losordo, D.W., Vale, P.R., Lathi, K.G., Esakof, D.D., Mayskiy, M., and Isner, J.M. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68, 830, 1999.
8. Laham, R.J., Sellke, F.W., Edelman, E.R., Pearlman, J.D., Ware, J.A., Brown, D.L., Gold, J.P., and Simons, M. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100, 1865, 1999.
9. Unger, E.F., Banai, S., Shou, M., Lazarous, D.F., Jaklitsch, M.T., Scheinowitz, M., Correa, R., Klingbeil, C., and Epstein, S.E. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 266, H1588, 1994.
10. Henry, T.D., Rocha-Singh, K., Isner, J.M., Kereiakes, D.J., Giordano, F.J., Simons, M., Losordo, D.W., Hendel, R.C., Bonow, R.O., Eppler, S.M., Zioncheck, T.F., Holmgren, E.B., and McCluskey, E.R. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J 142, 872, 2001.
11. Seiler, C., Pohl, T., Wustmann, K., Hutter D., Nicolet, P.A., Windecker, S., Eberli, F.R., and Meier, B. Promotion of collateral growth by granulocyte-macrophage colonystimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 104, 2012, 2001.
12. Mansbridge, J., Liu, K., Pinney, E., Patch, R, Ratcliffe, A., and Naughton, G. Growth factors secreted by fibroblasts: role in healing diabetic foot ulcers. Diabetes Obes Metab 1, 265, 1999.
13. Naughton, G., Mansbridge, J., and Gentzkow, G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs 21, 1203, 1997.
14. Kellar, R.S., Landeen, L.K., Shepherd, B.R., Naughton G.K., Ratcliffe A., and Williams S.K. Scaffold-based, threedimensional, human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue. Circulation 104, 2063, 2001.
15. Kellar, R.S., Shepherd, B.R., Naughton, G.K., Larson, D., and Williams S.K. A cardiac patch constructed from human fibroblasts attenuates a reduction in cardiac function following acute infarct. Tissue Eng. 11, 1678, 2005.
16. Thai, H.M., Juneman, E., Castellano, L., Do, R., Hagerty, T., Lancaster, J., Kellar, R.S., Williams, S., Sethi, G., Schmelz, M., Gaballa, M., and Goldman, S. Implantation of a 3 dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction. Cell Transplant 18, 283, 2009.
17. Lancaster, J.J., Elizabeth Juneman, E., Hagerty, T., Do, R., Hicks, M., Meltzer, K., Standley, P., Mohamed, A., Gaballa, M.A., Kellar, R.S., Goldman, S., and Thai, H. Viable fibroblast matrix patch induces angiogenesis and increases myocardial blood flow in heart failure after myocardial infarction. Tissue Eng 16, 3065, 2010.
18. Fitzpatrick, J.R., Frederick, J.R., McCormick, R.C., Harris, D.A., Kim, A.Y., Muenzer, J.R., Gambogi, A.J., Liu, J.P., Paulson, E.C., and Woo, Y.J. Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction. J Thorac Cardiovasc Surg 140, 667, 2010.
19. Lazarous, D.F., Shou, M., Stiber, J.A., Hodge, E., Thirumurti, V., Gonçalves, L., and Unger, E.F. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis. Cardiovasc Res 44, 294, 1999.
20. Shou, M., Thirumurti, V., Rajanayagam, S., Lazarous, D.F., Hodge, E., Stiber, J.A., Pettiford, M., Elliott, E., Shah, S.M., and Unger, E.F. Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels. J Am Coll Cardiol 29, 1102, 1997.
21. Unger, E.F. Experimental evaluation of coronary collateral development. Cardiovasc Res 49, 497, 2001.
22. Kern, A., Liu, K., and Mansbridge, J. Modification of fibroblast gamma-interferon responses by extracellular matrix. J Invest Dermatol 117, 112, 2001.
23. Rosenzweig, A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 355, 1274, 2006.
24. Meyer, G.P., Wollert, K.C., Lotz, J., Steffens, J., Lippolt, P., Fichtner, S., Hecker, H., Schaefer, A., Arseniev, L., Hertenstein, B., Ganser, A., and Drexler, H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 112, 1287, 2006.
25. Gerd, P., Meyer, G.P., Wollert, K.C., Lotz, J., Pirr, J., Rager, U., Lippolt, P., Hahn, A., Fichtner, S., Schaefer, A., Arseniev, L., Ganser, A., and Drexler, H. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 24, 2978, 2009.
26. Hofmann, M., Wollert, K.C., Meyer, G.P., Menke, A., Arseniev, L., Hertenstein, B., Ganser, A., Knapp,W.H., and Drexler, H. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111, 2198, 2005.